Clinical Trial Update: Durvalumab Consolidation After Chemoradiation Therapy for Limited Stage SCLC in China

View source ↗

Summary

This clinical trial update reports ongoing recruitment for durvalumab consolidation after chemoradiation in patients with limited-stage small cell lung cancer i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limited-stage Small Cell Lung Cancer

Drugs mentioned

• IMFINZI (DURVALUMAB)

Snippet

Sponsor: AstraZeneca | Conditions: Limited Stage Small-Cell Lung Cancer | Status: RECRUITING